(Q35146143)

English

EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

16

object named as

Claus Rödel

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Heinz-Josef Lenz

19

object named as

Heinz-Josef Lenz

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

object named as

Dirk Arnold

10

1 reference

ORCID Public Data File 2021

Siwen Hu-Lieskovan

1

object named as

Siwen Hu-Lieskovan

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Daniel Vallbohmer

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Wu Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dongyun Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alexander Pohl

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Melissa J Labonte

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Peter P Grimminger

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Arnulf H Hölscher

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert Semrau

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kathrin Dellas

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Annelies Debucquoy

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Karin Haustermans

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jean-Pascal H Machiels

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christine Sempoux

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Matej Bracko

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Vaneja Velenik

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

14 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5161-5169

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: a meta-analysis of 22 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Metabolism and effects of epidermal growth factor and related growth factors in mammals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

28 July 2018

Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Association between functional EGF+61 polymorphism and glioma risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

27 September 2018

Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3149732

8 December 2018

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The TME Trial After a Median Follow-up of 6 Years

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The EGF 61A/G polymorphism – a predictive marker for recurrence of liver metastases from colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between functional polymorphism in EGF gene and malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced Survival of Rectal Cancer Patients With Increased Tumor Epidermal Growth Factor Receptor Levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathological features of rectal cancer after preoperative radiochemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of surgery on metachronous distant metastases and survival in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No association between EGF gene polymorphism and gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21673069

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-10-2666

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35146143&oldid=1961359974"